Provider Account Engagement Strategy
Prioritize, Profile, Perform:
Powering Launch Success Across Provider Channels
Developing account-specific engagement strategies remains critical for successful launch planning, particularly in a rapidly evolving landscape of market consolidation and vertical integration. Combining robust expertise across IDNs, health systems & practices with proprietary account data-sets, The Dedham Group continues to be an industry leader in supporting account prioritization, profiling and tactical engagement planning across all provider channels.
Schedule a Meeting
Our Tailored Services for Account Strategy Success:
Targeting & Prioritization
Modeling:
Develop data-driven models to rank accounts based on patient volume, prescribing behaviors, and market potential.
Map and prioritize key decision-makers within health systems and IDNs to align engagement strategies with population health goals.
Flow Assessments:
Assess referral patterns and patient flow to identify key influencers and streamline strategies for improving patient access and outcomes.
Lever Analytics:
Analyze account performance metrics to identify growth opportunities and optimize tactical engagement strategies.
In-Depth Account Profiling
Account Profiling:
Develop tailored profiles that capture account-specific insights, including structure, priorities, and decision-making processes, to inform engagement strategies.
Support the integration of products into health system formularies and order sets, ensuring seamless adoption and alignment with clinical workflows.
& Analytics:
Identify and analyze key influencers within IDNs to understand decision-making pathways and optimize stakeholder engagement.
Evaluate existing workflows for adverse event reporting and management, recommending improvements to enhance compliance and patient safety.
Engagement Strategy
Segmentation:
Categorize accounts based on key attributes like size, influence, and access potential to tailor engagement strategies effectively.
Exchange (PIE) Strategy:
Develop strategies for compliant, proactive information exchange with key stakeholders to prepare for product launch and optimize market access.
Field Team Ways of Working:
Assess current engagement practices, benchmark against industry standards, and optimize field team approaches for greater impact.
Partnership Strategy:
Design strategies to strengthen partnerships with key accounts, aligning shared goals and enhancing collaboration.
& MSO Impact Assessments:
Analyze the influence of practice aggregators, private equity, and MSOs on market dynamics to inform targeting and engagement strategies.
We Provide:
Differentiated Market Research
Established relationships with KOLs & Key Decision-Makers across hundreds of accounts through Dedham’s fully owned research panel.
Extensive Account Strategy Experience
Dedicated teams of consultants with in-depth account knowledge ensure immediate expertise from kick-off to final deliverable.
Field Team
Socialization
Extensive experience socializing engagement strategies with field teams to ensure tactical pull-through & organization buy-in.
Related Resources:
How Bispecific Antibody Therapies are Impacting Community Practices, and Three Trends to Watch
As the oncology and hematology landscapes continue to evolve with the development of more complex therapies and competitive treatment options, bispecific antibody therapies (BsAbs) have emerged as a key player, particularly in the multiple myeloma and lymphoma markets. Here’s how manufacturers can manage expectations in terms of the adoption of these therapies, as well as three future trends to watch in the marketplace.
Defining “Academic” Cancer Centers: Navigating the Ambiguity
“How many academic cancer centers are there in the United States?” is a question that will receive answers ranging from 30 to well over 100, depending on who you ask. The confusion surrounding the definition of an academic cancer center can be attributed to many factors, but the reality is that the lack of clarity can have real-world implications on both patients and manufacturers.
